Immunomedics’ cancer treatment fails to win accelerated approval from the FDA

The company said it will request a meeting with the agency and work closely with the health regulator in its effort to launch the treatment as soon as possible.

WordPress › Error

There has been a critical error on this website.

Learn more about troubleshooting WordPress.